-- 加拿大皇家銀行資本市場(RBC Capital Markets)策略師週五在一份報告中指出,貝克休斯公司(Baker Hughes Company,股票代碼:BKR)公佈的第一季盈利超出預期,主要得益於其工業與能源技術(IET)和天然氣加工設備部門的強勁需求。 這家油田服務公司當季調整後EBITDA為11.6億美元,較去年同期成長12%,略高於先前9.8億美元至11.4億美元的預期區間上限。 RBC分析師表示,IET部門的強勁表現提振了整體成長,該部門EBITDA達到6.78億美元,超過了公司先前6億美元至6.5億美元的預期。 該部門的利潤率升至20.2%,年增310個基點,主要得益於積壓訂單轉換率的提高和專案執行效率的提升。 IET(工業、工程和運輸)業務的訂單表現依然強勁,本季訂單總額達49億美元,訂單出貨比為1.5。 貝克休斯表示對其訂單的持續時間和品質越來越有信心,指出其全年營收預期中位數145億美元以及長期目標超過400億美元的潛在成長空間。 加拿大皇家銀行(RBC)分析師表示,強勁的訂單和積壓訂單支撐了更樂觀的中期前景,並將2027年EBITDA預期上調3%。 貝克休斯維持第二季EBITDA預期約11.3億美元不變,並維持2026年全年預期不變,但預期實際業績將低於48.5億美元的預期中位數。 該指引假設中東地區的業務中斷將持續到6月份,霍爾木茲海峽的業務將在2026年下半年恢復正常。 加拿大皇家銀行(RBC)分析師表示,貝克休斯(Baker Hughes)仍處於有利地位,能夠從傳統的能源投資週期和新興能源技術的蓬勃發展中獲益,尤其是在關鍵地區的供應風險凸顯了冗餘和多元化的必要性的情況下。 加拿大皇家銀行維持對該股的「跑贏大盤」評級,並將目標價從68美元上調至71美元,該目標價基於其修訂後的2027年EBITDA預測的12.5倍市盈率計算得出。
Related Articles
Clinuvel Pharmaceuticals Advances Nasdaq ADR Uplisting With US SEC Review Underway
Clinuvel Pharmaceuticals (ASX:CUV) said it is working with the US Securities and Exchange Commission (SEC) on its draft registration statement as it advances plans to uplist its American depositary receipt (ADR) program on the Nasdaq stock market, according to a Tuesday filing with the Australian bourse.The company received four rounds of US SEC comments and expects the review process to be completed before the end of the fiscal year, after which it plans to upgrade its ADR program to level two from level one and list on Nasdaq under the revised ticker "CUVL," per the filing.The company stated that the uplisting is still subject to regulatory approval and Nasdaq requirements, and that its success and timing are not guaranteed, the filing added.
Greatland Resources Posts Lower March Quarter Gold Production; Shares Down 3%
Greatland Resources (ASX:GGP) said the March quarter production reached 82,723 ounces of gold and 4,128 tonnes of copper at an all-in sustaining cost (AISC) of AU$2,056 per ounce, according to a Tuesday Australian bourse filing.The company's December 2025 quarter production was of 86,273 ounces of gold and 3,528 tonnes of copper at an AISC of AU$2,196 per ounce, per the filing.The company reported sales of 97,800 ounces of gold and 4,620 tonnes of copper at weighted average realized prices of AU$6,773 per ounce and AU$15,803 per tonne, respectively, generating net revenue of AU$742 million.December 2025 quarter sales were 72,212 ounces of gold and 3,301 tonnes of copper at weighted average realized prices of AU$6,301 per ounce and AU$14,652 per tonne, respectively, generating net revenue of AU$507 million.Greatland said it expects fiscal 2026 production to be around or slightly above the upper end of its guidance range of 260,000 to 310,000 ounces, with AISC trending toward the lower end of the AU$2,400 to AU$2,800 per ounce guidance range.Greatland Resources' shares fell 3% in recent Tuesday trade.
Research Alert: Nucor Posts Strong Q1, Beats On Revenue And Eps
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Nucor reported Q1 2026 adjusted EPS of $3.23, significantly above $0.77 prior year and beating consensus by $0.41, with revenues of $9.50B exceeding estimates by 7.1%. Steel mills posted record quarterly shipments of 7.0M tons with segment earnings more than doubling sequentially to $1.128B as external pricing improved to $1,074 per ton (+14% Y/Y) and utilization climbed to 86%. We believe operational execution remains strong across segments, with steel products earnings rising 24% sequentially and broad-based volume recovery evident. Management guided for higher Q2 earnings across all segments on price improvement and stable to growing volumes. With capex declining 18% sequentially to $661M and $2.48B in cash, Nucor returned $250M to shareholders with $3.97B remaining under buyback authorization. We expect accelerating free cash flow generation will support enhanced shareholder returns, though valuation ultimately depends on pricing power persistence amid upcoming industry capacity additions in 2027.